The Column Group – Startup Investor Profile

The Column Group is a venture capital firm dedicated to developing biotechnology companies.

Location: 1700 Owens Street

Country: United States of America

Investment Regions:

Investment Stages: seed, series-a

Website: http://www.thecolumngroup.com/

AI Reasoning: I found evidence of The Column Group participating in investments and portfolio/press updates dated Oct 2025 (e.g., Synthekine announcement, RAPT Therapeutics trial news, Remix Therapeutics data) and other 2025 activity listed on their portfolio/news pages. The most recent publicly noted investment-related activity is in October 2025 involving portfolio companies such as Synthekine, RAPT Therapeutics and Remix Therapeutics. That is less than three months prior to the date used for classification, which places the investor in the highest activity category.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.